ZEPP earnings

Earnings Call Scheduled for 9:30 p.m. ET on March 15, 2026MILPITAS, Calif., March 10, 2026 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced that it will report its fourth quarter and full year 2025 unaudited financial results on Sunday, March 15, 2026. Management will hold a conference call at 9:30 p.m. Eastern Time on Sunday, March 15, 2026. Listeners may access the call by dialing:US (Toll Free):+1-888-346-8982International:+1-412-902-4272Mainland China (Toll Free):400-120-1203Hong Kong (Toll Free):800-905-945Participants should dial in at least 10 minutes before the scheduled sta

MILPITAS, Calif., Nov. 4, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today announced its unaudited financial results for the third quarter of 2025. Third Quarter 2025 Financial and Operating Highlights: Revenue reached US$75.8 million, representing 78.5% year-over-year growth, meeting the upper end of our guidance range.GAAP and adjusted operating result[1] was loss of US$0.9 million and income of US$0.4 million, compared with loss of US$12.5 million and US$11.3 million in the third quarter of 2024. We achieved adjusted operating income breakeven, which marks a key milestone on our path to sustained profitability.As of September 30, 2025, cash and cas

Earnings Call Scheduled for 8:30 p.m. ET on November 4, 2025 MILPITAS, Calif., Oct. 20, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced that it will report its third quarter 2025 unaudited financial results after the market close on Tuesday, November 4, 2025. Management will hold a conference call at 8:30 p.m. Eastern Time on Tuesday, November 4, 2025. Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kong (Toll Free): 800-905-945 Hong Kong: +852-3018-4992 Participants should

MILPITAS, Calif., Aug. 3, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today announced its unaudited financial results for the second quarter of 2025. Second Quarter 2025 Financial and Operating Highlights: Revenue reached US$59.4 million, representing 46.2% year-over-year growth and surpassing the high end of the guidance range announced previously.GAAP and adjusted net loss[1] was US$7.7 million and US$6.16 million, which narrowed by 28.6% and 30.2% compared with the second quarter of 2024.For the third quarter of 2025, management currently expects net revenues to be between US$72.0 million and US$76.0 million, which would represent a year-over-year i

Earnings Call Scheduled for 9:30 p.m. ET on August 3, 2025 MILPITAS, Calif., July 14, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced that it will report its second quarter 2025 unaudited financial results on Sunday, August 3, 2025. Management will hold a conference call at 9:30 p.m. Eastern Time on Sunday, August 3, 2025. Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kong (Toll Free): 800-905-945 Hong Kong: +852-3018-4992 Participants should dial in at least 10 minutes b

MILPITAS, Calif., May 19, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today announced its unaudited financial results for the first quarter of 2025. First Quarter 2025 Financial and Operating Highlights: Revenue reached US$39 million, out of which Amazfit-branded products grew by 10.2% year-over-year.Gross margin was 37.3% compared with 36.8% in the same period of last yearCash balance was 104 million, after repayment of US$11.5 million short-term debt in the first quarter of 2025.The U.S.-China reached deal to temporarily reduce tariffs; the company has proactively established a dual-sourcing supply chain strategy with production bases in both China a

Earnings Call Scheduled for 9:00 p.m. ET on May 19, 2025 MILPITAS, Calif., May 7, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced that it will report its first quarter 2025 unaudited financial results after the market close on Monday, May 19, 2025. Management will hold a conference call at 9:00 p.m. Eastern Time on Monday, May 19, 2025. Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kong (Toll Free): 800-905-945 Hong Kong: +852-3018-4992 Participants should dial in at leas

MILPITAS, Calif., March 26, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today announced its unaudited financial results for the fourth quarter of 2024. Fourth Quarter 2024 Financial and Operating Highlights: Revenue reached US$59.5 million representing a 40.2% of quarter over quarter increase, out of which our Amazfit-branded products grew by 43.4% quarter-over-quarter.Gross margin was 36.8% compared with 34.7% in the same period last year.Adjusted operating loss[1] was US$7.4 million, which was the lowest level in 2024.Full Year 2024 Financial and Operating Highlights: Gross margin was 38.5% compared with 26.2% in the full year of 2023.Adjusted operat

Earnings Call Scheduled for 7:00 p.m. ET on March 26, 2025 MILPITAS, Calif., March 18, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced that it will report its fourth quarter and full year 2024 unaudited financial results after the market close on Wednesday, March 26, 2025. Management will hold a conference call at 7:00 p.m. Eastern Time on Wednesday, March 26, 2025. Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kong (Toll Free): 800-905-945 Hong Kong: +852-3018-4992 Parti

MILPITAS, Calif., Nov. 18, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenues of US$42.5 million; a basic and diluted net loss per share of US$0.05; and a basic and diluted net loss per ADS of US$0.82 for the third quarter ended September 30, 2024; adjusted basic and diluted net loss per share of US$0.05; and adjusted basic and diluted net loss per ADS of US$0.78. Each ADS represents sixteen Class A ordinary shares. Mr. Wang 'Wayne' Huang, Chairman and CEO of Zepp, commented, "I'm pleased to report that this quarter our Amazfit branded sales had a 10% quarter-over-quarter increase, the highest sequential growth we've achieved this year

Earnings Call Scheduled for 8:30 p.m. ET on November 18, 2024 MILPITAS, Calif., Nov. 5, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced that it will report its third quarter 2024 unaudited financial results after the market close on Monday, November 18, 2024. Management will hold a conference call at 8:30 p.m. Eastern Time on Monday, November 18, 2024. Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kong (Toll Free): 800-905-945 Hong Kong: +852-3018-4992 Participants should

MILPITAS, Calif., Aug. 21, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenues of US$40.6 million; a basic and diluted net loss per share of US$0.04; and a basic and diluted net loss per ADS of US$0.17 for the second quarter ended June 30, 2024; adjusted basic and diluted net loss per share of US$0.04; and adjusted basic and diluted net loss per ADS of US$0.15. Each ADS represents four Class A ordinary shares. Starting from the second quarter of 2024, the Company changed its reporting currency from Renminbi ("RMB") to U.S.dollar ("US$"), to reduce the impact of increased volatility of the RMB to US$ exchange rate on the Company's report

Earnings Call Scheduled for 9:30 p.m. ET on August 21, 2024 MILPITAS, Calif., Aug. 8, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report its second quarter 2024 unaudited financial results after the market close on Wednesday, August 21, 2024. Management will hold a conference call at 9:30 p.m. Eastern Time on Wednesday, August 21, 2024 (9:30 a.m. Beijing Time on August 22, 2024). Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong

MILPITAS, Calif., May 20, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenues of US$39.8 million; a basic and diluted net loss per share of US$0.06; and a basic and diluted net loss per ADS of US$0.23 for the first quarter ended March 31, 2024; adjusted basic and diluted net loss per share of US$0.05; and adjusted basic and diluted net loss per ADS of US$0.19. Each ADS represents four Class A ordinary shares. Mr. Wang 'Wayne' Huang, Chairman and CEO of Zepp, commented, "In the first quarter of 2024, our revenue came broadly in line with our guidance. Our gross margin performance reached a record high, and our self-branded product sales

Earnings Call Scheduled for 7:00 p.m. ET on May 20, 2024 MILPITAS, Calif., May 8, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report its first quarter 2024 unaudited financial results after the market close on Monday, May 20, 2024. Management will hold a conference call at 7:00 p.m. Eastern Time on Monday, May 20, 2024 (7:00 a.m. Beijing Time on May 21, 2024). Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kong (Toll Free): 80

MILPITAS, Calif., March 18, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenues of US$84.5 million (RMB0.6 billion); a basic and diluted net loss per share of US$0.005 (RMB0.03); and a basic and diluted net loss per ADS of US$0.02 (RMB0.14) for the fourth quarter ended December 31, 2023; adjusted basic and diluted net income per share of US$0.002 (RMB0.01); and adjusted basic and diluted net income per ADS of US$0.01 (RMB0.06). Each ADS represents four Class A ordinary shares. Mr. Wang 'Wayne' Huang, Chairman and CEO of Zepp, commented, "In the fourth quarter, we continued to make substantial progress in our strategic transformation, a

Earnings Call Scheduled for 7:00 p.m. ET on March 18, 2024 AMSTERDAM, March 7, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report its fourth quarter and full year 2023 unaudited financial results after the market close on Monday, March 18, 2024. Management will hold a conference call at 7:00 p.m. Eastern Time on Monday, March 18, 2024 (7:00 a.m. Beijing Time on March 19, 2024). Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Ko

AMSTERDAM, Nov. 20, 2023 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenues of RMB0.6 billion (US$82.5 million); a basic and diluted net income per share of RMB0.01 (US$0.002); and a basic and diluted net income per ADS of RMB0.05 (US$0.01) for the third quarter ended September 30, 2023. Each ADS represents four Class A ordinary shares. Mr. Wayne Wang Huang, Chairman and CEO of Zepp, commented, "In the third quarter, we achieved a business turnaround, returning to profitability after six loss-making quarters. Despite a year-over-year revenue decline, our high-margin self-branded products' contribution to our top line grew to approximately 8

AMSTERDAM, Aug. 21, 2023 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenues of RMB0.65 billion (US$89.4 million); a basic and diluted net loss per share of RMB0.29 (US$0.04); and a basic and diluted net loss per ADS of RMB1.15 (US$0.16) for the second quarter ended June 30, 2023. Each ADS represents four Class A ordinary shares. "In the second quarter of 2023, we were delighted to witness our strategic transformation from a company heavily reliant on a single customer for revenue to becoming a self-reliant, global smart wearable and healthcare solution provider yielding early success, as our self-branded products contributed 68% of our top l

Earnings Call Scheduled for 8:30 a.m. ET on August 21, 2023 BEIJING, Aug. 9, 2023 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report its second quarter 2023 unaudited financial results before the market open on Monday, August 21, 2023. Management will hold a conference call at 8:30 a.m. Eastern Time on Monday, August 21, 2023 (8:30 p.m. Beijing Time on August 21, 2023). Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kong (Toll Free)

BEIJING, May 23, 2023 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenues of RMB0.6 billion (US$93.9 million); a GAAP basic and diluted net loss per share of RMB0.56 (US$0.08); and a GAAP basic and diluted net loss per ADS of RMB2.23 (US$0.32) for the first quarter ended March 31, 2023. Each ADS represents four Class A ordinary shares. "Our first quarter revenue came in within our guidance range at RMB645.2 million, including 60% of self-branded revenue. Total revenue down 14.8% year-over-year, the decrease is mainly due to the macroeconomic uncertainties globally that dampened discretionary consumption especially in the electronic devices ma

Earnings Call Scheduled for 8:00 a.m. ET on May 23, 2023 BEIJING, May 10, 2023 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report its first quarter 2023 unaudited financial results before the market open on Tuesday, May 23, 2023. Management will hold a conference call at 8:00 a.m. Eastern Time on Tuesday, May 23, 2023 (8:00 p.m. Beijing Time on May 23, 2023). Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kong (Toll Free): 800-905-9

BEIJING, March 21, 2023 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenues of RMB1.1 billion (US$155.4 million); a GAAP basic and diluted net loss per share of RMB0.31 (US$0.04); and a GAAP basic and diluted net loss per ADS of RMB1.23 (US$0.18) for the fourth quarter ended December 31, 2022. Each ADS represents four Class A ordinary shares. "Despite the macro challenges that weighed on our overall performance in 2022, our self-branded products achieved a 28.5% quarter-over-quarter increase in revenue and continued gross margin expansion in the fourth quarter." said Wang Huang, Chairman and CEO of Zepp Health. "The encouraging growth margin

Earnings Call Scheduled for 8:00 a.m. ET on March 21, 2023 BEIJING, March 8, 2023 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report its fourth quarter and full year 2022 unaudited financial results before the market open on Tuesday, March 21, 2023. Management will hold a conference call at 8:00 a.m. Eastern Time on Tuesday, March 21, 2023 (8:00 p.m. Beijing Time on March 21, 2023). Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kon

BEIJING, Nov. 21, 2022 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenues of RMB1.2 billion (US$169.5 million); a GAAP diluted net loss per share of RMB0.07 (US$0.01); and a GAAP diluted net loss per ADS of RMB0.28 (US$0.04) for the third quarter ended September 30, 2022. Each ADS represents four Class A ordinary shares. "While challenging macro dynamics persist, we further improved our top line on a quarter-over-quarter basis and restored growth in sales of our self-branded products in the third quarter, thanks to our unremitting efforts in product innovation as well as our strong channel and go-to-market capabilities. For example, in the N

Earnings Call Scheduled for 7:30 a.m. ET on November 21, 2022 BEIJING, Nov. 8, 2022 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report its third quarter 2022 unaudited financial results before the market open on Monday, November 21, 2022. Management will hold a conference call at 7:30 a.m. Eastern Time on Monday, November 21, 2022 (8:30 p.m. Beijing Time on November 21, 2022). Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kong (Tol

BEIJING, Aug. 25, 2022 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenues of RMB1.1 billion (US$165.5 million); GAAP diluted net loss per share of RMB0.44 (US$0.07); and GAAP diluted net loss per ADS of RMB1.74 (US$0.26) for the second quarter ended June 30, 2022. Each ADS represents four Class A ordinary shares. "Our second quarter revenues improved from the first quarter, which highlights our execution capabilities, product strength and disciplined business management approach, in the face of macro economic challenges. We achieved RMB1.1 billion in revenues, representing a 46.4% increase quarter-over-quarter. Our year-over-year revenues de

Earnings Call Scheduled for 8:00 a.m. ET on August 25, 2022 BEIJING, Aug. 11, 2022 /PRNewswire/ -- Zepp Health Corp. ("Zepp Health" or the "Company") (NYSE:ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report its second quarter 2022 unaudited financial results before the market open on Thursday, August 25, 2022. Management will hold a conference call at 8:00 a.m. Eastern Time on Thursday, August 25, 2022 (8:00 p.m. Beijing Time on August 25, 2022). Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kong (Toll Free):

BEIJING, May 24, 2022 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenue of RMB0.8 billion (US$119.4 million); GAAP diluted net loss per share of RMB0.36 (US$0.06); and GAAP diluted net loss per ADS of RMB1.42 (US$0.22) for the first quarter ended March 31, 2022. Each ADS represents four Class A ordinary shares. "We achieved RMB0.8 billion in revenue in the first quarter, meeting our guidance range despite the pandemic resurgence and a slowdown in consumer discretionary spending due to geopolitical and macroeconomic factors during the quarter," said Wang Huang, Chairman and CEO of Zepp Health. "Amid all the challenges around us, our fundament

Earnings Call Scheduled for 8:00 a.m. ET on May 24, 2022 BEIJING, May 9, 2022 /PRNewswire/ -- Zepp Health Corp. ("Zepp Health" or the "Company") (NYSE:ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report its first quarter 2022 unaudited financial results before the market open on Tuesday, May 24, 2022. Management will hold a conference call at 8:00 a.m. Eastern Time on Tuesday, May 24, 2022 (8:00 p.m. Beijing Time on May 24, 2022). Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kong (Toll Free): 800-905-945 Hong

BEIJING, March 17, 2022 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenue of RMB1.7 billion (US$260.7 million); GAAP diluted net income per share of RMB0.14 (US$0.02); and GAAP diluted net income per ADS of RMB0.55 (US$0.09) for the fourth quarter ended December 31, 2021. Each ADS represents four Class A ordinary shares. "In 2021, we advanced our Amazfit and Zepp brands, elevated our technology, further enriched our product portfolio, and closed the year with revenues in line with our revised fourth quarter guidance," said Wang Huang, Chairman and CEO of Zepp Health. "Despite the challenges posed by the global macro-environment, shipment vol

BEIJING, March 1, 2022 /PRNewswire/ -- Zepp Health Corp. ("Zepp Health" or the "Company") (NYSE:ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report its fourth quarter and full year 2021 unaudited financial results before the market open on Thursday, March 17, 2022. Management will hold a conference call at 8:00 a.m. Eastern Time on Thursday, March 17, 2022 (8:00 p.m. Beijing Time on March 17, 2022). Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kong (Toll Free): 800-905-945 Hong Kong: +852-3018-4992 Participa